Geron to Present at Needham Healthcare Conference
April 02 2019 - 3:30PM
Geron Corporation (Nasdaq: GERN) today announced that John A.
Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled
to present a company overview at the 18th Annual Needham Healthcare
Conference in New York at 3:30 p.m. ET on Tuesday, April 9, 2019.
A live audio webcast of the presentation will be
available on Geron’s website, www.geron.com/investors/events. If
you are unable to listen to the live presentation, an archived
webcast will be available on the Company’s website for 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical
company focused on the development and potential commercialization
of a first-in-class telomerase inhibitor, imetelstat, in
hematologic myeloid malignancies. For more information about Geron,
visit www.geron.com.
CONTACT:
Suzanne MessereInvestor and Media
Relationsinvestor@geron.commedia@geron.com
CG Capital877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2024 to May 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From May 2023 to May 2024